普鲁兰多糖在药物释放系统中的应用

本综述重点介绍了近年来普鲁兰多糖作为药物释放系统载体材料的研究进展及其在药物释放系统中的应用情况。     

高分子包囊药物释放体系

用高分子作为载体的高分子微包囊和纳米级包囊药物制剂不仅能控制药物以一定的速度释放，而且可对生物体的生理指标变化作出反馈，因而可以成为靶向药物释放体系。通过用高分子包囊还可以延长蛋白质和多肽类药物的生理活性，提高药物稳定性，使之成为长效药物，并使一些难以口服的药物能够制成口服制剂。文章在介绍有关高分子药物释放体系的一些基本原理，以及与之相关的药学、药理学、物理化学和高分子材料科学方面知识的基础上，较全面地综述了高分子包囊药物的制备技术和应用。阐述了高分子包囊的粒径、表面积、孔度、药物性能和药含量，以及高分子包囊材料的性能对药物释放行为的影响。对药物传送机理亦进行了扼要的介绍。     

可生物降解聚合物药物释放数学模拟研究进展

由于可降解的聚合物作为药物载体可以使得药物释放具有较高的靶向性、药物释放更加平缓 ,特别是可以使一些不稳定、半衰期短的药物在人体内达到可控制释放的效果 ,因此将可降解聚合物应用于药物释放体系中作为药物载体得到了较深入的研究。随着研究的深入 ,通过数学方法模拟或预测聚合物载体的降解过程以及聚合物降解过程中药物的释放行为是控释体系设计与应用的一个重要发展方向。由于影响因素较多 ,将所有因素逐一考虑将使得数学模型过于庞杂而失去实际意义 ,所以一个数学模型通常只考虑最主要几个的影响因素 ,并对药物释放系统进行相应的假设。目前文献中报道的降解 (溶蚀 )控制药物释放体系的数学模型大致可以分为两类 :假设药物释放按照零级过程 (zeroorderprocess)进行的经验模型和考虑影响药物释放的多种物理化学过程(如局部传质、化学反应 )的理论模型。本文综述了这些理论模型及其研究进展     

超临界流体技术在制备药物输送系统中的应用

超临界流体技术以其特有的优点成为引人注目的制备药物细微粒子及控制释放的药物输送系统的方法。本文介绍了超临界流体沉淀技术的概念、进展及相关的应用。     

控制释放技术

综述药物控制释放的种类，机理，高分子材料在控制释放技术中的应用。     

生物可降解聚磷酸酯的合成及其释药性能研究

生物可降解聚磷酸酯的合成及其释药性能研究罗毅，卓仁禧，范昌烈（武汉大学化学系，武汉，４３００７２）关键词聚磷酸酯，５－氟尿嘧啶，药物控制释放高分子控制释放材料的研究、发展及其在药物制剂中的应用对提高药物的持续性和专一性研究产生了突破，通过控制释放材料...     

光控释药型药物递送系统的研究进展

释药可控的药物递送系统能够在特定刺激条件下,在时间和空间上精确实现在病灶处释放包载的药物分子,具有药物利用率高、毒副作用低等诸多优点,为各种重大疾病,如肿瘤的精准治疗提供了新思路.在众多的可控释药递送系统中,利用特定光照控制药物释放的光控释药型药物递送系统展现出广阔的应用潜力,受到研究者的广泛关注.近年来,基于不同光响应机理的光控释药型药物递送系统被设计开发用于药物的精确可控释放,本文介绍了四种光敏感基团的不同光响应机理,对基于不同光响应机理的光控释药型药物递送系统的研究进展进行了综述,指出现有光控释药型药物递送系统存在的问题及对未来的研究方向进行了展望.     

交联补强硅橡胶包埋18-甲基炔诺酮的释放行为

甲基乙烯基硅橡胶;交联补强硅橡胶包埋18-甲基炔诺酮的释放行为;药物释放系统     

控制药物释放体系及其机理

药物控制释放是目前药物学发展的一个重要领域,用于药物控制释放的载体一般是高分子材料。本文主要介绍药物控制释放的种类、机理、高分子材料及其应用。     

基于HPMCP包覆介孔SBA-15的pH敏感药物缓释系统

以肠溶性包衣材料羟丙甲纤维素邻苯二甲酸酯(HPMCP)为原料,在负载法莫替丁(Famo)的SBA-15药片表面包覆聚合物膜,成功制备了一种新型的pH敏感药物缓释系统, 并考察了此缓释系统在不同pH释放环境中的释放行为. 结果表明: 在模拟胃液中(SGF, pH=1.2),HPMCP能致密包覆在药片表面,从而明显延缓Famo的释放速度;而在模拟肠液中(SIF, pH=7.5),HPMCP能够迅速溶于缓释溶液中,因而对Famo释放速度的影响甚微. 因此,可以将这种新型智能药物缓释系统应用于肠道靶向给药.     

Bipolymeric Pectin Millibeads Doped with Functional Polymers as Matrices for the Controlled and Targeted Release of Mesalazine

Targeted drug delivery systems are a very convenient method of treating inflammatory bowel disease. The properties of pectin make this biopolymer a suitable drug carrier. These properties allow pectin to overcome the diverse environment of the digestive tract and deliver the drug to the large intestine. This investigation proposed bipolymeric formulations consisting of the natural polymer pectin and a synthetic polymer containing the drug 5-aminosalicylic acid. Pectin beads were prepared via ionotropic gelation involving the interaction between the hydrophilic gel and calcium ions. The obtained formulations consisted of natural polymer, 5-aminosalicylic acid (5-ASA) and one of the synthetic polymers, such as polyacrylic acid, polyvinylpyrrolidone, polyethylene glycol or aristoflex. The release of the drug was carried out employing a basket apparatus (USP 1). The acceptor fluid was pH = 7.4 buffer with added enzyme pectinase to reflect the colon environment. The amount of the released drug was determined using UV-Vis spectrophotometry at a wavelength of λ = 330 nm. The kinetics of the drug dissolution revealed that none of the employed models was appropriate to describe the release process. A kinetic analysis of the release profile during two release stages was carried out. The fastest drug release occurred during the first stage from a formulation containing pectin and polyethylene glycol. However, according to the applied kinetic models, the dissolution of 5-ASA was rather high in the formulation without the synthetic polymer during the second stage. Depending on the formulation, 68–77% of 5-ASA was released in an 8-hour time period. The FTIR and DSC results showed that there was no interaction between the drug and the polymers, but interactions between pectin and synthetic polymers were found.     

聚膦腈在药物控释系统中的应用

聚膦腈由于其具有良好的生物相容性，可生物降解性及易于功能化的特性而成为一类独特的药物控释材料。本文就疏水性线型聚膦腈，聚膦腈水凝胶及聚膦腈高分子药物在药物控释系统中的应用作一简要综述。     

盐酸维拉帕米药物树脂复合物的制备及其体外释药动力学

口服药物树脂控释给药系统;交换反应动力学;盐酸维拉帕米药物树脂复合物的制备及其体外释药动力学     

Green Algae as a Drug Delivery System for the Controlled Release of Antibiotics

New strategies to efficiently treat bacterial infections are crucial to circumvent the increase of resistant strains and to mitigate side effects during treatment. Skin and soft tissue infections represent one of the areas suffering the most from these resistant strains. We developed a new drug delivery system composed of the green algae, Chlamydomonas reinhardtii, which is generally recognized as safe, to target specifically skin diseases. A two-step functionalization strategy was used to chemically modify the algae with the antibiotic vancomycin. Chlamydomonas reinhardtii was found to mask vancomycin and the insertion of a photocleavable linker was used for the release of the antibiotic. This living drug carrier was evaluated in presence of Bacillus subtilis and, only upon UVA1-mediated release, growth inhibition of bacteria was observed. These results represent one of the first examples of a living organism used as a drug delivery system for the release of an antibiotic by UVA1-irradiation.     

Surface-modulated and thermoresponsive polyphosphoesternanoparticles for enhanced intracellular drug delivery

The chemical structure of end groups influenced the phase transition temperature of thermoresponsive polymers. We demonstrated a strategy for the preparation of the pH/thermo-responsive polymeric nanoparticles via subtle modification of end groups of thermoresponsive polymer segments with a carboxyl group and revealed its potential application for enhanced intracellular drug delivery. By developing a polymeric nanoparticle composed of poly(aliphatic ester) as the inner core and thermoresponsive polyphosphoester as the outer shell, we showed that end groups of thermoresponsive polyphosphoester segments modified by carboxyl groups exhibited a pH/thermo-responsive behavior due to the hydrophilic to hydrophobic transitions of the end groups in response to the pH. Moreover, by encapsulating doxorubicin into the hydrophobic core of such pH/thermo-responsive polymer nanoparticles, their intracellular delivery and cytotoxicity to wild-type and drug-resistant tumor cells were significantly enhanced through the phase-transition-dependent drug release that was triggered by endosomal/lysosomal pH. This novel strategy and the multi-responsive polymer nanoparticles achieved by the subtle chain-terminal modification of thermoresponsive polymers provide a smart platform for biomedical applications.     

Effect of microsphere size on the drug release and experimental characterization of an electrospun naringin‐loaded microsphere/sucrose acetate isobutyrate (SAIB) depot

The aims of this study were to prepare different sizes of electrospun naringin‐loaded microspheres (Ng‐ms) and investigate the effects of the particle size of these microspheres on drug release from naringin‐loaded microsphere/sucrose acetate isobutyrate (Ng‐m‐SAIB) hybrid depots to develop an improved drug delivery system for tissue engineering. Different sizes of microspheres were produced using electrospray methods by controlling electrospinning parameters. The Ng‐m‐SAIB depots were prepared by dispersing Ng‐ms in SAIB depots. The morphology and size distributions of the electrospun Ng‐ms were characterized by polarizing microscopy and scanning electron microscopy (SEM). To better understand the release behavior of Ng‐m‐SAIB, the porosity of SAIB depots was measured. Consequently, both small (2.51 ± 0.191 μm) and large (5.03 ± 0.172 μm) microspheres exhibited smooth surfaces and good monodispersity. The initial and long‐term drug release rates of the large microspheres were lower than those of small microspheres. On the first day after 2.5‐μm and 5‐μm Ng‐m‐SAIB depots were produced, the burst release reduced dramatically from 68.79% to 3.30% and from 63.20% to 0.00%, respectively. After 92 days of release, the drug release rate of 5‐μm Ng‐m‐SAIB was still lower than that of 2.5‐μm Ng‐m‐SAIB, with values of 58.54% and 63.93%, respectively. These results demonstrate that drug release from Ng‐m‐SAIB depots can be tailored solely by varying the size of the microspheres and that good drug release behavior occurred.     

Controlled release of drug via tuning electrospun polymer carrier

Medicated‐fibers have been obtained through electrospinning after rifampin was dissolved in poly (lactic acid)/chloroform solution. The relationship between polymer variables [such as concentration, molecular weight (M_w), and introducing hydrophilic block] and drug release from the electrospun fibers is disclosed. The results show that polymeric concentration and M_w are crucial for producing the medicated fibers, which influence not only the morphology of the medicated‐fiber but also drug release rate from fiber. At the same M_w, the drug release rate decreases with the increase of spinning concentration. At two different M_w blends, drug release behaviors change. When the low M_w content is in a dominant position, drug release rate depends largely on mixing ratio of two M_w contents; on the other hand, drug release rate is also dependent on concentration of spinning fluid. In addition, the block copolymer [poly‐L ‐lactic acid (PLLA)‐polyethylene glycol‐PLLA] shows faster release rate as compared to homopolymer (PLLA). © 2011 Wiley Periodicals, Inc. J Polym Sci Part B: Polym Phys, 2011